J. Safra Sarasin Holding’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118M Buy
481,585
+2,782
+0.6% +$648K 2.01% 6
2025
Q4
$99.1M Sell
478,803
-7,873
-2% -$1.56M 1.61% 12
2025
Q3
$90.2M Buy
486,676
+16,155
+3% +$2.77M 1.46% 14
2025
Q2
$71.9M Buy
470,521
+100,541
+27% +$15.5M 1.24% 22
2025
Q1
$61.4M Buy
369,980
+48,334
+15% +$7.56M 1.11% 32
2024
Q4
$46.5M Buy
321,646
+9,541
+3% +$1.48M 0.79% 43
2024
Q3
$50.6M Sell
312,105
-12,099
-4% -$1.93M 0.88% 42
2024
Q2
$47.4M Buy
+324,204
New +$48.2M 0.87% 41

Other funds holding JNJ

J. Safra Sarasin Holding's JNJ Position: Q1 2026 in Review

J. Safra Sarasin Holding increased its Johnson & Johnson (JNJ) stake by 0.58% in Q1 2026, buying an estimated $648K and bringing the position to 481,585 shares worth $118M. The position accounts for 2.01% of the portfolio, ranked #6.

J. Safra Sarasin Holding first reported a position in JNJ in Q2 2024 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • J. Safra Sarasin Holding held 481,585 shares of Johnson & Johnson worth $118M as of Q1 2026.
  • J. Safra Sarasin Holding bought 2,782 Johnson & Johnson shares in Q1 2026, an estimated $648K.
  • Johnson & Johnson made up 2.01% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #6 holding.
  • J. Safra Sarasin Holding first reported a position in Johnson & Johnson in Q2 2024 and has held it in 8 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.